Back to board

ViiV Healthcare (GSK) Scientific Leader, Pre-clinical DMPK Drug Discovery Modeling

GSK · 4 Locations · GB

Pharma Strategy
–
Not yet analysed
Demand60
Career growth65
Healthcare fit35
Remote potential40
5-year outlook
Senior pharma R&D scientific leader roles typically offer competitive compensation and stability, but exact figures depend on location, experience, and company band; no salary data is provided in the posting.
Clinical license
Not required
Applicant reach
narrow
Seniority
lead
Employment type
–
Date found
2026-10-02

Intelligence details

Flexible work details

Eligible countries
United Kingdom

Eligibility, licensing, and location restrictions can change. Always confirm details on the source posting before applying.

Why this is worth applying to

Only consider if you have strong DMPK, pharmacometrics, or computational drug discovery experience; most clinicians without that specialized background would not be competitive.

Who should apply

PharmDs/PhDs in pharmacokinetics, clinical pharmacology, pharmacometrics, or computational biology; MD/PhDs with drug development modeling experience; scientists with PBPK/QSP and ADME modeling backgrounds.

CV angle

Frame any real PK/PD, pharmacometrics, modeling-and-simulation, or drug development experience; emphasize cross-functional collaboration with discovery, clinical, and regulatory teams, and quantify model impact on candidate selection or dose prediction. Do not claim DMPK leadership without direct evidence.

Skills to highlight

  • DMPK modeling
  • Pharmacokinetics (PK)
  • Pharmacodynamics (PD)
  • PBPK modeling
  • QSP modeling
  • ADME
  • Modeling and simulation
  • Drug discovery

Role summary

Lead preclinical DMPK modeling for ViiV Healthcare/GSK, using computational and simulation approaches to predict drug metabolism, pharmacokinetics, and exposure to support drug discovery and development decisions.

We publish our own intelligence summary, never the full job description. Always confirm details with the employer when you apply.